One of the many initiatives by the Abu Dhabi Health department is the launch of Abu Dhabi Stem Cell centre, which has successfully managed to continue its implementation of the Abu Dhabi Bone Marrow Transplant program.

The transplant was first introduced in July 2020 and since then many of the patients have been treated with this technique. According to the latest reports, as many as six patients received blood malignancies and are recovering well and quickly from this dangerous disease.

The programme was directed by ADSCC with the aim to provide the highest standard of care in this field of Hematopoietic Stem Cells Transplant. The officials started to admit patients seeking the treatments from August last year and since then the trust of people has only increased for this program.

The programme includes different types of blood malignancies ranging from Multiple Myeloma, Plasma Cell Leukemia, Large Diffuse B-Cell Lymphoma and Hodgkin Lymphoma. However, all these are different types of treatments and the recovery time of each one is different. It can take up to 19 days to one month to complete the recovery cycle.

The programme has been exceptionally successful and that has resulted in ADSCC to seek international accreditation for the treatment plan. With the accreditation, ADSCC will be looking further with this programme and ensuring a comprehensive approach so that proper and more efficient use of technology can be done.

They are also making sure that the use of technology remains eco-friendly and sustainable to the other aspects. This approach will help in setting a platform for this programme and furthermore facilitate the expansion of this technology for other procedures and operations as well.

The Bone marrow Transplant programme is looking at expansion and is aiming at being able to treat more that one patient at a time. This will enable them to treat not only those with hematological conditions but also those who have been struggling with autoimmune diseases and primary immune deficiencies.

WAM